{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:21:18Z","timestamp":1777594878639,"version":"3.51.4"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2013,9,2]],"date-time":"2013-09-02T00:00:00Z","timestamp":1378080000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0071994","type":"journal-article","created":{"date-parts":[[2013,9,2]],"date-time":"2013-09-02T20:45:45Z","timestamp":1378154745000},"page":"e71994","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["ERCC1 and ERCC2 Variants Predict Survival in Gastric Cancer Patients"],"prefix":"10.1371","volume":"8","author":[{"given":"Yangkai","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhensheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-E","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongfeng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaffer A.","family":"Ajani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Yi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,9,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"A Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"R Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/sj.ejhg.5201884","article-title":"Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population","volume":"15","author":"B Liu","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-230X-12-137","article-title":"Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum\/5-Fu-based chemotherapy: a systematic review","volume":"12","author":"Z Wang","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/JTO.0b013e3182272273","article-title":"Combined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survival","volume":"6","author":"L Liu","year":"2011","journal-title":"J Thorac Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1200\/JCO.2010.34.3616","article-title":"DNA repair capacity in peripheral lymphocytes predicts survival of patients with non-small-cell lung cancer treated with first-line platinum-based chemotherapy","volume":"29","author":"LE Wang","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref7","article-title":"Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer","author":"L Liu","year":"2012","journal-title":"Mol Carcinog"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.embor.7400418","article-title":"Mismatch repair participates in error-free processing of DNA interstrand crosslinks in human cells","volume":"6","author":"Q Wu","year":"2005","journal-title":"EMBO Rep"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/mc.20069","article-title":"Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies","volume":"42","author":"AS Neumann","year":"2005","journal-title":"Mol Carcinog"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1097-2765(01)00281-7","article-title":"Sequential assembly of the nucleotide excision repair factors in vivo","volume":"8","author":"M Volker","year":"2001","journal-title":"Mol Cell"},{"key":"ref11","first-page":"1354","article-title":"Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients","volume":"61","author":"MR Spitz","year":"2001","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/carcin\/21.4.551","article-title":"XPD polymorphisms: effects on DNA repair proficiency","volume":"21","author":"RM Lunn","year":"2000","journal-title":"Carcinogenesis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/FPC.0b013e3280115e63","article-title":"Single nucleotide polymorphisms of the DNA repair gene XPD\/ERCC2 alter mRNA expression","volume":"17","author":"KJ Wolfe","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1158\/1055-9965.EPI-06-0218","article-title":"Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer","volume":"15","author":"J Shen","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref15","first-page":"555","article-title":"Comparison of two human ovarian carcinoma cell lines (A2780\/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene","volume":"16","author":"JJ Yu","year":"2000","journal-title":"Int J Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.lungcan.2008.08.006","article-title":"Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature","volume":"64","author":"A Vilmar","year":"2009","journal-title":"Lung Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e33200","DOI":"10.1371\/journal.pone.0033200","article-title":"Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients","volume":"7","author":"W Wu","year":"2012","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/tpj.2011.33","article-title":"Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy","volume":"12","author":"P Biason","year":"2012","journal-title":"Pharmacogenomics J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.7314\/APJCP.2012.13.11.5721","article-title":"Association Between Polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln Genes and Prognosis of Colorectal Cancer in a Chinese Population","volume":"13","author":"Y Gan","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"E94","DOI":"10.1002\/mc.21868","article-title":"Polymorphisms in GSTM1 and XPD genes predict clinical outcome in advanced oral cancer patients treated with postoperative radiotherapy","volume":"51 Suppl 1","author":"MB Mahimkar","year":"2012","journal-title":"Mol Carcinog"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.3748\/wjg.v12.i37.6032","article-title":"Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated with chemo-radiotherapy","volume":"12","author":"RN Zarate","year":"2006","journal-title":"World J Gastroenterol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1158\/1078-0432.CCR-10-2169","article-title":"ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis","volume":"17","author":"M Yin","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1158\/1055-9965.EPI-07-0252","article-title":"Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck","volume":"16","author":"J An","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0197-2456(90)90005-M","article-title":"Power and sample size calculations. A review and computer program","volume":"11","author":"WD Dupont","year":"1990","journal-title":"Control Clin Trials"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0197-2456(98)00037-3","article-title":"Power and sample size calculations for studies involving linear regression","volume":"19","author":"WD Dupont","year":"1998","journal-title":"Control Clin Trials"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/carcin\/23.2.295","article-title":"Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD\/ERCC2 genotypes","volume":"23","author":"Y Qiao","year":"2002","journal-title":"Carcinogenesis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.lungcan.2009.03.007","article-title":"Effects of excision repair cross-complementation group 1 (ERCC1) single nucleotide polymorphisms on the prognosis of non-small cell lung cancer patients","volume":"67","author":"T Takenaka","year":"2010","journal-title":"Lung Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2478\/v10039-011-0013-3","article-title":"Lack of correlation between ERCC1 (C8092A) single nucleotide polymorphism and efficacy\/toxicity of platinum based chemotherapy in Chinese patients with advanced non-small cell lung cancer","volume":"56","author":"V KimCurran","year":"2011","journal-title":"Adv Med Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.arcmed.2011.07.008","article-title":"Polymorphisms of ERCC1 C118T\/C8092A and MDR1 C3435T predict outcome of platinum-based chemotherapies in advanced non-small cell lung cancer: a meta-analysis","volume":"42","author":"HB Wei","year":"2011","journal-title":"Arch Med Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1667\/RR3400","article-title":"Influence of polymorphisms in DNA repair genes XPD, XRCC1 and MGMT on DNA damage induced by gamma radiation and its repair in lymphocytes in vitro","volume":"164","author":"J Rzeszowska-Wolny","year":"2005","journal-title":"Radiat Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/mutage\/17.6.463","article-title":"ERCC2\/XPD gene polymorphisms and cancer risk","volume":"17","author":"S Benhamou","year":"2002","journal-title":"Mutagenesis"},{"key":"ref32","first-page":"7430","article-title":"Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp\/Asp genotype","volume":"61","author":"H Seker","year":"2001","journal-title":"Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.bjc.6601975","article-title":"A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU\/oxaliplatin combination chemotherapy in refractory colorectal cancer","volume":"91","author":"J Stoehlmacher","year":"2004","journal-title":"Br J Cancer"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2217\/pgs.10.196","article-title":"Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxaliplatin regimen in patients with metastatic colorectal cancer","volume":"12","author":"MJ Lamas","year":"2011","journal-title":"Pharmacogenomics"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1471-2407-8-148","article-title":"Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker","volume":"8","author":"B Keam","year":"2008","journal-title":"BMC Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.lungcan.2010.11.004","article-title":"Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy","volume":"73","author":"L Liu","year":"2011","journal-title":"Lung Cancer"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0071994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T07:58:05Z","timestamp":1688457485000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0071994"}},"subtitle":[],"editor":[{"given":"Xiaoping","family":"Miao","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,9,2]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0071994","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,2]]}}}